FDA says knockoff versions of weight loss drug must come off the market

Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and diabetes will have to phase out their versions next year under a federal government decision issued Thursday. The Food and Drug Administration announced that a nationwide shortage of Eli Lilly's Zepbound and Munjaro has been eliminated, eliminating […]